Clinical Trial Update: Itacitinib Pre-modulation in DLBCL Receiving CAR T Cell Therapy [Phase 2]

View source ↗

Summary

This clinical trial update indicates that Itacitinib is being studied as pre-modulation therapy in patients with diffuse large B-cell lymphoma receiving CAR T-c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• Itacitinib (itacitinib)

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Diffuse Large B Cell Lymphoma | Phase 2 | Status: RECRUITING